Major Rating Factors:
Poor long-term capitalization index (0.0 on a scale of 0 to 10) based on weak current risk adjusted capital (severe and moderate loss scenarios). A history of deficient reserves (2.2). Underreserving can have an adverse impact on capital and profits. In four of the last five years reserves (two year development) were between 22% and 45% deficient.
Other Rating Factors:
Weak profitability index (0.4). Weak expense controls. Weak overall results on stability tests (0.0) including weak risk adjusted capital in prior years, weak results on operational trends and negative cash flow from operations for 2022. Excellent liquidity (7.0) with ample operational cash flow and liquid investments.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
F - Negative cash flow.
R - Concerns about the financial strength of its reinsurers.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (100.0%)
Licensed in:
NY
Principal Investments:
Investment grade bonds (50.3%), common stock (13.5%), non investment grade bonds (8.4%), real estate (3.7%), cash (3.3%), other (20.8%)